$PFE Recent Headlines Why tax inversions are b
Post# of 44882
Posted On: 08/16/2014 10:58:42 AM
$PFE Recent Headlines
Why tax inversions are bad for shareholders 4:03 p.m. Aug. 15, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
AbbVie, Shire set to announce merger as early as Friday: report 4:54 a.m. July 18, 2014 - blogs.marketwatch.com
Top 10 Net Payout Yield Stocks For August 2014 8:44 p.m. Aug. 15, 2014 - Seeking Alpha
3 Stocks Underperforming Today In The Drugs Industry 1:04 p.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 15, 2014 - Market News 10:10 a.m. Aug. 15, 2014 - Zacks.com
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog 5:10 p.m. Aug. 14, 2014 - Zacks.com
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 4:01 p.m. Aug. 14, 2014 - benzinga.com
The 4 Stocks That Carried the Market 3:33 p.m. Aug. 14, 2014 - 247WallSt.com
Why Pfizer (PFE) Stock Is Up Today 8:25 a.m. Aug. 14, 2014 - TheStreet.com
Buyback Mania Inflates 2Q Earnings Growth 8:17 a.m. Aug. 14, 2014 - FOXBusiness
Opportunity in the Melee 5:16 p.m. Aug. 13, 2014 - Barrons.com
First Eagle Fund Plays All the Angles 5:13 p.m. Aug. 13, 2014 - Barrons.com
Drug Patent Expirations This Week: Pfizer's Nicotine Spray, Transdermal Hormones 3:02 p.m. Aug. 13, 2014 - Seeking Alpha
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog 9:10 a.m. Aug. 13, 2014 - Zacks.com
UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog 5:05 p.m. Aug. 12, 2014 - Zacks.com
Pfizer Issues Top-Line Results from Potherpetic Neuralgia, Painful Diabetic Peripheral Neuropathy Studies in China: PDPN Phase 3 Did Not Hit Endpoint, PHN Phase 4 Study Met Primary Endpoint 4:04 p.m. Aug. 12, 2014 - benzinga.com
The 4 Stocks That Weighed on the Market 3:13 p.m. Aug. 12, 2014 - 247WallSt.com
Key Short Interest Changes in Defensive High-Yield Dividend Stocks 10:13 a.m. Aug. 12, 2014 - 247WallSt.com
Time To Panic Over Lipitor Litigation? 10:05 a.m. Aug. 11, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: PFE, WMT, UTX 9:59 a.m. Aug. 11, 2014 - TheStreet.com
Retirement Strategy: Some Dividend Champions Are On Sale Right Now 3:51 a.m. Aug. 11, 2014 - Seeking Alpha
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 5:01 p.m. Aug. 14, 2014 - BusinessWire - BZX
Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older 5:43 p.m. Aug. 13, 2014 - BusinessWire - BZX
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic PeripheralNeuropathy Lyrica® Studies Conducted in China 5:03 p.m. Aug. 12, 2014 - BusinessWire - BZX
Study Links Viagra(R) to Skin Cancer 11:20 a.m. Aug. 12, 2014 - Marketwire
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Renal Pain Global Clinical Trials Review, H2, 2014 4:37 p.m. Aug. 11, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults 8:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer 9:10 a.m. July 31, 2014 - PR Newswire - PRF
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 10:33 a.m. July 30, 2014 - PR Newswire - PRF
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer 8:02 a.m. July 30, 2014 - BusinessWire - BZX
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines 8:02 a.m. July 30, 2014 - BusinessWire - BZX
BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS 7:06 a.m. July 29, 2014 - GlobeNewswire
European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:03 a.m. July 29, 2014 - BusinessWire - BZX
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Why tax inversions are bad for shareholders 4:03 p.m. Aug. 15, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
AbbVie, Shire set to announce merger as early as Friday: report 4:54 a.m. July 18, 2014 - blogs.marketwatch.com
Top 10 Net Payout Yield Stocks For August 2014 8:44 p.m. Aug. 15, 2014 - Seeking Alpha
3 Stocks Underperforming Today In The Drugs Industry 1:04 p.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 15, 2014 - Market News 10:10 a.m. Aug. 15, 2014 - Zacks.com
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog 5:10 p.m. Aug. 14, 2014 - Zacks.com
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 4:01 p.m. Aug. 14, 2014 - benzinga.com
The 4 Stocks That Carried the Market 3:33 p.m. Aug. 14, 2014 - 247WallSt.com
Why Pfizer (PFE) Stock Is Up Today 8:25 a.m. Aug. 14, 2014 - TheStreet.com
Buyback Mania Inflates 2Q Earnings Growth 8:17 a.m. Aug. 14, 2014 - FOXBusiness
Opportunity in the Melee 5:16 p.m. Aug. 13, 2014 - Barrons.com
First Eagle Fund Plays All the Angles 5:13 p.m. Aug. 13, 2014 - Barrons.com
Drug Patent Expirations This Week: Pfizer's Nicotine Spray, Transdermal Hormones 3:02 p.m. Aug. 13, 2014 - Seeking Alpha
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog 9:10 a.m. Aug. 13, 2014 - Zacks.com
UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog 5:05 p.m. Aug. 12, 2014 - Zacks.com
Pfizer Issues Top-Line Results from Potherpetic Neuralgia, Painful Diabetic Peripheral Neuropathy Studies in China: PDPN Phase 3 Did Not Hit Endpoint, PHN Phase 4 Study Met Primary Endpoint 4:04 p.m. Aug. 12, 2014 - benzinga.com
The 4 Stocks That Weighed on the Market 3:13 p.m. Aug. 12, 2014 - 247WallSt.com
Key Short Interest Changes in Defensive High-Yield Dividend Stocks 10:13 a.m. Aug. 12, 2014 - 247WallSt.com
Time To Panic Over Lipitor Litigation? 10:05 a.m. Aug. 11, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: PFE, WMT, UTX 9:59 a.m. Aug. 11, 2014 - TheStreet.com
Retirement Strategy: Some Dividend Champions Are On Sale Right Now 3:51 a.m. Aug. 11, 2014 - Seeking Alpha
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 5:01 p.m. Aug. 14, 2014 - BusinessWire - BZX
Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older 5:43 p.m. Aug. 13, 2014 - BusinessWire - BZX
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic PeripheralNeuropathy Lyrica® Studies Conducted in China 5:03 p.m. Aug. 12, 2014 - BusinessWire - BZX
Study Links Viagra(R) to Skin Cancer 11:20 a.m. Aug. 12, 2014 - Marketwire
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Renal Pain Global Clinical Trials Review, H2, 2014 4:37 p.m. Aug. 11, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults 8:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer 9:10 a.m. July 31, 2014 - PR Newswire - PRF
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 10:33 a.m. July 30, 2014 - PR Newswire - PRF
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer 8:02 a.m. July 30, 2014 - BusinessWire - BZX
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines 8:02 a.m. July 30, 2014 - BusinessWire - BZX
BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS 7:06 a.m. July 29, 2014 - GlobeNewswire
European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:03 a.m. July 29, 2014 - BusinessWire - BZX
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼